178 related articles for article (PubMed ID: 11447714)
21. Congenital vulnerability of cutaneous segments arising from skin mosaicism: A genetic basis for locus minoris resistentiae.
Al-Rohil RN; Leung D; Carlson JA
Clin Dermatol; 2014; 32(5):577-91. PubMed ID: 25160099
[TBL] [Abstract][Full Text] [Related]
22. Opportunistic Pulmonary Infections in Immunocompromised Hosts.
Rali P; Veer M; Gupta N; Singh AC; Bhanot N
Crit Care Nurs Q; 2016; 39(2):161-75. PubMed ID: 26919677
[TBL] [Abstract][Full Text] [Related]
23. Approach to the immunocompromised host with infection in the intensive care unit.
Linden PK
Infect Dis Clin North Am; 2009 Sep; 23(3):535-56. PubMed ID: 19665082
[TBL] [Abstract][Full Text] [Related]
24. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification.
Viscoli C; Varnier O; Machetti M
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S240-5. PubMed ID: 15768329
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system infections in the compromised host: a diagnostic approach.
Cunha BA
Infect Dis Clin North Am; 2001 Jun; 15(2):567-90. PubMed ID: 11447710
[TBL] [Abstract][Full Text] [Related]
26. Community-acquired pneumonia in immunocompromised patients. Opportunistic infections to consider in differential diagnosis.
Cebular S; Lee S; Tolaney P; Lutwick L
Postgrad Med; 2003 Jan; 113(1):65-6, 69-70, 73-4 passim. PubMed ID: 12545593
[TBL] [Abstract][Full Text] [Related]
27. Dermatologic immune restoration syndrome: report of five cases from a tertiary care center in north India.
Handa S; Narang T; Wanchu A
J Cutan Med Surg; 2008; 12(3):126-32. PubMed ID: 18544296
[TBL] [Abstract][Full Text] [Related]
28. [Gram-positive cocci as an opportunistic infection factor].
Szczerba I
Pol Merkur Lekarski; 2005 Apr; 18(106):462-4. PubMed ID: 16161935
[TBL] [Abstract][Full Text] [Related]
29. Treatment of fungal and other opportunistic infections in immunocompromised patients.
Wade JC
Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
[TBL] [Abstract][Full Text] [Related]
30. Capnocytophaga bacteremia in neutropenic patients: report of two cases.
López R; Martino R; Pericas R; Altés A; Sureda A; Brunet S
Acta Haematol; 1994; 92(1):46-7. PubMed ID: 7985483
[No Abstract] [Full Text] [Related]
31. Fine needle aspiration biopsy of postvaccination disseminated Mycobacterium bovis infection presenting as a solitary cutaneous papule.
Peart LK; Schneider JW; Jordaan HF; Wright CA
Acta Cytol; 2005; 49(2):230-1. PubMed ID: 15839637
[No Abstract] [Full Text] [Related]
32. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
[TBL] [Abstract][Full Text] [Related]
33. Opportunistic localization of skin lesions on vulnerable areas.
Ruocco V; Ruocco E; Brunetti G; Sangiuliano S; Wolf R
Clin Dermatol; 2011; 29(5):483-8. PubMed ID: 21855722
[TBL] [Abstract][Full Text] [Related]
34. The immunocompromised district in dermatology: A unifying pathogenic view of the regional immune dysregulation.
Ruocco V; Ruocco E; Piccolo V; Brunetti G; Guerrera LP; Wolf R
Clin Dermatol; 2014; 32(5):569-76. PubMed ID: 25160098
[TBL] [Abstract][Full Text] [Related]
35. Diseases and drug-related interventions affecting host defence.
de Marie S
Eur J Clin Microbiol Infect Dis; 1993; 12 Suppl 1():S36-41. PubMed ID: 8477761
[TBL] [Abstract][Full Text] [Related]
36. Dermatologic manifestations as indicators of immune status in HIV/AIDS.
Lutwak N; Dill C
J Gen Intern Med; 2012 Jul; 27(7):765. PubMed ID: 22528623
[No Abstract] [Full Text] [Related]
37. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
38. The life-threatening eruption in HIV and immunosuppression.
Ramos-E-Silva M; Secchin P; Trope B
Clin Dermatol; 2020; 38(1):52-62. PubMed ID: 32197749
[TBL] [Abstract][Full Text] [Related]
39. Empiric therapy for the immunocompromised host.
Armstrong D
Rev Infect Dis; 1991; 13 Suppl 9():S763-9. PubMed ID: 1925322
[TBL] [Abstract][Full Text] [Related]
40. Leishmaniasis: recognition and management with a focus on the immunocompromised patient.
Choi CM; Lerner EA
Am J Clin Dermatol; 2002; 3(2):91-105. PubMed ID: 11893221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
